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Aim: Self-Management is key for Cystic Fibrosis (CF). Low self-esteem, a common
ﬁnding among patients with chronic conditions, may hamper treatment adherence.
We characterized the relationship between social support, self-esteem and patient-
reported outcomes in adolescents with CF.
Methods: Twenty-two Italian CF referral centers joined the LINFA group. We
enrolled 168 adolescents with the disease and their parents (n = 225). Participants
answered a self-administered questionnaire (child: SF-12, Rosemberg’s Self-Esteem,
Multidimensional Social Support, Barriers to Adherence, CFQOL, Shared Decision
Making, Family Communication Style, MRC Dyspnea scale; parent: Depression-
Happiness Scale, Self-Rated Health, socio-demographic factors, caregiver burden).
A pediatrician recorded clinical information (pulmonary exacerbations, complica-
tions, treatment, BMI, Fev1 %).
Results: Mean age was 16±2.6 and mean BMI was 19±3.0; 96 adolescents
(66%) had FEV1% >70. About 66% of patients reported to experience at least
one barrier to adherence sometimes or more often. The average SF-12 MCS
and PCS were 49.9±8.5 and 49.0±10.0 respectively. The mean Treatment Issue
scale score of the CFQOL was 11.9±4.5. SEM analysis showed that self-esteem
mediated the relationship between support from family and psychological well-
being, treatment-issues and barriers to adherence. Shared decision making and open
family communication were associated with greater support from family and self-
esteem.
Conclusion: Social support from family might enhance well-being by strengthening
self-esteem. We also have identiﬁed relational correlates of self-esteem which may
be amenable of psychological interventions.
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Objectives: Self-reported adherence overestimates true adherence and is 14% above
pharmacy script collection in our population. Our aim was to investigate the
presence of objective measures which could predict self reported adherence.
Methods: Patients completed a self-report of adherence (CFQ-R). They were
subsequently classiﬁed into one of 3 categories: low (<60%), moderate (60−80%),
good (>80%) according to a mean of their score from the CFQ-R adherence score
and conﬁrmation against prescribed medications. Coefﬁcient of variation (CoV) for
FEV1, weight and CRP were each calculated from all clinical contacts within the
previous year. Age, gender, microbial status, disease severity, medication, respira-
tory and anthropometric measures were collected at baseline. Ordinal regression
was used to determine the contribution of objective variables to adherence.
Results: 249 patients [age 29.7(±9.2) yrs, 58.6% M] completed the study. Regres-
sion analysis revealed that CoV FEV1 [OR= 0.95; CI: 0.92–0.98, p = 0.006], number
of types of medication [OR= 1.18; CI: 1.11–1.26, p< 0.001], and age [OR= 1.03;
CI: 1.01 to 1.06, p = 0.026] together explained 19% of the variance in the model,
classiﬁed as having good ﬁt. Banding status, gender, microbial status, genotype,
CoV weight, and Cov CRP did not predict adherence.
Conclusion: Although adherence is complex in aetiology, we have shown that 3
objective measures can predict almost 20% of the model. The odds of being in a
higher adherence category increase for every year of age, each 1% reduction in
CoV FEV1, and each additional medication.
